Gabapentin is a γ-aminobutyric acid analog formally indicated for the treatment of epilepsy and neuropathic pain that is gaining increased popularity. Gabapentin has been historically considered a safe medication, including during pregnancy and lactation, with low reported concerns for misuse and us Gabapentin and pregnancy. Gabapentin is not generally recommended in pregnancy as there is not enough information about whether it's safe for your baby. However, from the small amount of information that is available, there's no clear evidence that it's harmful. It should only be taken if the benefits of the medicine outweigh the risks. In this study with over 4000 infants exposed to gabapentin, the information is reassuring. While we cannot rule out the possibility of a small increase in risk of cardiovascular malformations in gabapentin-exposed infants, gabapentin does not appear to be a major teratogen. Every pregnancy starts out with a 3-5% chance of having a birth defect. This is called the background risk. Small, controlled studies on gabapentin have not suggested an increased chance of birth defects. There is also no known pattern of birth defects associated with the use of gabapentin in pregnancy. Gabapentin has been historically considered a safe medication, including during pregnancy and lactation, with low reported concerns for misuse and use disorders. However, new empirical efforts are revealing concerns regarding the safety of widespread gabapentin use, particularly in pregnancy and for individuals with a propensity toward To provide evidence on the safety of gabapentin use in pregnancy, we conducted a large. cohort study of pregnant women within the US Medicaid Analytic eXtract (MAX) [12] and. In pregnant women, a European study found that the prescribing of pregabalin and gabapentin during pregnancy has increased markedly in the United Kingdom from around 0.3 per 1000 in 2007 to 2.5–3.0 per 1000 in 2016, with about one-seventh of prescriptions likely intended for pain management [7]. A less pronounced increase was observed in Gabapentin Pregnancy and Breastfeeding Warnings. Brand names: Fanatrex, Gabarone, Gralise, Neurontin. Pregnancy Warnings; Breastfeeding Warnings; Gabapentin Pregnancy Warnings. Benefits should clearly outweigh risks AU TGA pregnancy category: B3 US FDA pregnancy category: Not assigned The aim of this study was to provide an overview of all available data on the use and safety of gabapentinoids during pregnancy. Methods: A systematic review was performed in PubMed and Reprotox using the search terms: "gabapentin", "pregabalin", "antiepileptic drugs" and terms associated with pregnancy. We included all studies in English that When treating neuropathic pain in a woman who is pregnant, the use of gabapentinoids (e.g. gabapentin) or an antiepileptic drug (AED) (e.g. levetiracetam, lamotrigine) is a last line option. This is due to the limited availability of data for safe use during pregnancy. Other options should be trialled first. The safety of the use of gabapentin in pregnant women has always been a serious issue, as gabapentin can cross placental barriers. The impact of gabapentin on brain development in the fetus is not sufficiently investigated, which poses difficulties in clinical decisions regarding prescriptions. In this large population-based study, we did not find evidence for an association between gabapentin exposure during early pregnancy and major malformations overall, although there was some evidence of a higher risk of cardiac malformations. Maternal use of gabapentin, particularly late in pregnancy Does taking gabapentin in pregnancy increase the chance of other pregnancy-related problems? Pregnancy-related problems, such as preterm delivery (birth before week 37) or low birth weight (weighing less than 5 pounds, 8 ounces [2500 grams] at birth) have been reported in some studies looking at the use of gabapentin during pregnancy. of gabapentin exposure on the rates of maternal com-plications, cesarean sections, low birth weight babies, fetalloss,andprematurity. Maternal complications were minimal among study All pregnant women in the UK will be offered a very detailed anomaly scan at around 20 weeks of pregnancy as part of their routine antenatal care. No extra monitoring for major birth defects is required following gabapentin use in pregnancy. Babies exposed to gabapentin before delivery may experience withdrawal symptoms for a few days after birth. Every pregnancy starts out with a 3-5% chance of having a birth defect. This is called the background risk. Small, controlled studies on gabapentin have not suggested an increased chance of birth defects. There is also no known pattern of birth defects associated with the use of gabapentin in pregnancy. Because of the increasing use of gabapentin in many settings of care and the limited information on its safety in pregnancy, there is a critical need for evidence to help pregnant women or women of childbearing age and their healthcare providers to balance the risks and benefits of gabapentin treatment with regard to pregnancy-related outcomes. The drug was approved by the US Food and Drug Administration for use in epilepsy in 1993 and subsequently for neuropathic pain in 2002. 2 However, despite the increasing number of patients receiving gabapentin, there is only limited information regarding the safety of this medication when used during pregnancy. Congenital malformations play a critical role in foetal death, and the occurrence of malformations in pregnant people exposed to gabapentin poses a serious concern. 9, 12 Further studies on the safety of gabapentin and neonatal outcomes are required owing to the rising trend in its use and the scarcity of evidence on its safety during pregnancy Because of the increasing use of gabapentin in many settings of care and the limited information on its safety in pregnancy, there is a critical need for evidence to help pregnant women or women of childbearing age and their healthcare providers to balance the risks and benefits of gabapentin treatment with regard to pregnancy-related outcomes.
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
![]() | |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() |